{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:32:14Z","timestamp":1718375534787},"reference-count":29,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej23-0062","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T22:13:26Z","timestamp":1686953606000},"page":"833-837","source":"Crossref","is-referenced-by-count":3,"title":["Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves\u2019 disease: a case report"],"prefix":"10.1507","volume":"70","author":[{"given":"Kento","family":"Shimmaru","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital &amp; Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan"},{"name":"Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Inami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital &amp; Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Hamaoka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital &amp; Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital &amp; Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Kamei","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital &amp; Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, et al. (2018) 2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J 7: 167\u2013186.","DOI":"10.1159\/000490384"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Brix TH, Kyvik KO, Christensen K, Heged\u00fcs L (2001) Evidence for a major role of heredity in Graves\u2019 disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86: 930\u2013934.","DOI":"10.1210\/jc.86.2.930"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y (2015) Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun 64: 82\u201390.","DOI":"10.1016\/j.jaut.2015.07.009"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM (2003) Risk factors for and prevalence of thyroid disorders in a cross\u2010sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 59: 396\u2013401.","DOI":"10.1046\/j.1365-2265.2003.01862.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G (1991) High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area <i>vs.<\/i> high incidence of Graves\u2019 disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East\u2010Jutland Denmark and Iceland. J Intern Med 229: 415\u2013420.","DOI":"10.1111\/j.1365-2796.1991.tb00368.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Brix TH, Hansen PS, Kyvik KO, Heged\u00fcs L (2000) Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med 160: 661\u2013666.","DOI":"10.1001\/archinte.160.5.661"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, et al. (2013) Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab 98: 3671\u20133677.","DOI":"10.1210\/jc.2013-1954"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Struja T, Fehlberg H, Kutz A, Guebelin L, Degen C, et al. (2017) Can we predict relapse in Graves\u2019 disease? Results from a systematic review and meta-analysis. Eur J Endocrinol 176: 87\u201397.","DOI":"10.1530\/EJE-16-0725"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Bandai S, Okamura K, Fujikawa M, Sato K, Ikenoue H, et al. (2019) The long-term follow-up of patients with thionamide-treated Graves\u2019 hyperthyroidism. Endocr J 66: 535\u2013545.","DOI":"10.1507\/endocrj.EJ18-0418"},{"key":"10","unstructured":"10 Sultana I, Alam JM, Ali HH, Noureen S (2020) Reproducibility, repeatability and precision analysis of thyroid function tests (TFT) on two, separately operated-LRS integrated Roche Cobas e411 iECL analyzers. Chem Res J 5: 151\u2013156."},{"key":"11","unstructured":"11 Kazerouni F, Amirrasouli H (2012) Performance characteristics of three automated immunoassays for thyroid hormones. Caspian J Internal Med 3: 400\u2013404."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Favresse J, Lardinois B, Nassogne MC, Preumont V, Maiter D, et al. (2018) Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests. Clin Chem Lab Med 56: e160\u2013e163.","DOI":"10.1515\/cclm-2017-1027"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Favresse J, Paridaens H, Pirson N, Maiter D, Gruson D (2017) Massive interference in free T4 and free T3 assays misleading clinical judgment. Clin Chem Lab Med 55: e84\u2013e86.","DOI":"10.1515\/cclm-2016-0255"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Favresse J, Burlacu MC, Maiter D, Gruson D (2018) Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev 39: 830\u2013850.","DOI":"10.1210\/er.2018-00119"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Said HM (2012) Biotin: biochemical, physiological and clinical aspects. Subcell Biochem 56: 1\u201319.","DOI":"10.1007\/978-94-007-2199-9_1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV (2016) Factitious Graves\u2019 disease due to biotin immunoassay interference\u2014a case and review of the literature. J Clin Endocrinol Metab 101: 3251\u20133255.","DOI":"10.1210\/jc.2016-1971"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Garg U (2020) Biotin interference in certain immunoassays: risk of misdiagnosis and mismanagement. J Appl Lab Med 5: 436\u2013439.","DOI":"10.1093\/jalm\/jfaa040"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Holmes EW, Samarasinghe S, Emanuele MA, Meah F (2017) Biotin interference in clinical immunoassays: a cause for concern. Arch Pathol Lab Med 141: 1459\u20131460.","DOI":"10.5858\/arpa.2017-0107-LE"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Piketty ML, Prie D, Sedel F, Bernard D, Hercend C, et al. (2017) High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med 55: 817\u2013825.","DOI":"10.1515\/cclm-2016-1183"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Baumgartner MR (2013) Vitamin-responsive disorders: cobalamin, folate, biotin, vitamins B1 and E. Handb Clin Neurol 113: 1799\u20131810.","DOI":"10.1016\/B978-0-444-59565-2.00049-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Piketty ML, Souberbielle JC (2017) Biotin: an emerging analytical interference. Ann Biol Clin (Paris) 75: 366\u2013368 (In French).","DOI":"10.1684\/abc.2017.1252"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kummer S, Hermsen D, Distelmaier F (2016) Biotin treatment mimicking Graves\u2019 disease. N Engl J Med 375: 704\u2013706.","DOI":"10.1056\/NEJMc1602096"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 De Roeck Y, Philipse E, Twickler TB, Van Gaal L (2018) Misdiagnosis of Graves\u2019 hyperthyroidism due to therapeutic biotin intervention. Acta Clin Belg 73: 372\u2013376.","DOI":"10.1080\/17843286.2017.1396676"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ardabilygazir A, Afshariyamchlou S, Mir D, Sachmechi I (2018) Effect of high-dose biotin on thyroid function tests: case report and literature review. Cureus 10: e2845.","DOI":"10.7759\/cureus.2845"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Barbesino G (2016) Misdiagnosis of Graves\u2019 disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 26: 860\u2013863.","DOI":"10.1089\/thy.2015.0664"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Pedersen IB, Laurberg P (2016) Biochemical hyperthyroidism in a newborn baby caused by assay interaction from biotin intake. Eur Thyroid J 5: 212\u2013215.","DOI":"10.1159\/000448034"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Batista MC, Ferreira CE, Faulhaber AC, Hidal JT, Lottenberg SA, et al. (2017) Biotin interference in immunoassays mimicking subclinical Graves\u2019 disease and hyperestrogenism: a case series. Clin Chem Lab Med 55: e99\u2013e103.","DOI":"10.1515\/cclm-2016-0628"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kwok JSS, Chan IHS, Chan MHM (2012) Biotin interference on TSH and free thyroid hormone measurement. Pathology 44: 278\u2013280.","DOI":"10.1097\/PAT.0b013e3283514002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Henry JG, Sobki S, Arafat N (1996) Interference by biotin therapy on measurement of TSH and FT4 by enzyme immunoassay on Boehringer Mannheim ES700 analyser. Ann Clin Biochem 33: 162\u2013163.","DOI":"10.1177\/000456329603300214"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/8\/70_EJ23-0062\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:48:51Z","timestamp":1715575731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/8\/70_EJ23-0062\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej23-0062","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ23-0062"}}